Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.

Employees - 21, CEO - Mr. Dane Carl Andreeff, Sector - Healthcare, Country - US, Market Cap -

Altman ZScore(max is 10): -83.12, Piotroski Score(max is 10): 3, Working Capital: $1382000, Total Assets: $3484000, Retained Earnings: $-175537000, EBIT: -14458000, Total Liabilities: $2204000, Revenue: $434000

- Current Price $ - Analyst Target Price $